Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Cooper

Showing results (71-80 of 324) with videos related to

Pageof 33
Sort By:
AIDS (London, England)|July 30, 2005
Evaluation of ultrasound for assessing facial lipoatrophy in a randomized, placebo-controlled trialDianne Carey, Handan Wand, Allison Martin, et al.
Journal of Chemical Information and Modeling|January 17, 2025
Intracellular Pocket Conformations Determine Signaling Efficacy through the μ Opioid ReceptorDavid A Cooper, Joseph DePaolo-Boisvert, Stanley A Nicholson, et al.
AIDS Research and Human Retroviruses|June 3, 2005
A new variant cytotoxic T lymphocyte escape mutation in HLA-B27-positive individuals infected with HIV type 1Palanee Ammaranond, John Zaunders, Claudette Satchell, et al.
Plos One|November 3, 2011
Predictors of limb fat gain in HIV positive patients following a change to tenofovir-emtricitabine or abacavir-lamivudineAllison Martin, Janaki Amin, Sean Emery, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2024
Intracellular pocket conformations determine signaling efficacy through the <math></math> opioid receptorDavid A Cooper, Joseph DePaolo-Boisvert, Stanley A Nicholson, et al.
Sexual Health|January 9, 2017
Managing two decades of visceral leishmaniasis and HIV co-infection: a case report that illustrates the urgent research needs in the fieldMelissa L Kelly, Angie N Pinto, Dan Suan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 27, 2012
Tuberculosis after commencing antiretroviral therapy for HIV infection is associated with elevated CXCL9 and CXCL10 responses to Mycobacterium tuberculosis antigensBenjamin G Oliver, Julian H Elliott, Patricia Price, et al.
AIDS (London, England)|December 4, 2002
Thymidine analogue withdrawal for lipoatrophic patients on protease-sparing therapy improves lipoatrophy but compromises antiviral control: the PIILR extension studyDon E Smith, Andrew Carr, Matthew Law, et al.
Journal of Clinical Epidemiology|April 29, 2018
National characteristics and trends in antiretroviral treatment in Australia can be accurately estimated using a large clinical cohortRobin Huang, Kathy Petoumenos, Richard T Gray, et al.
Microbes and Infection|February 24, 2009
Retroviral delivery of promoter-targeted shRNA induces long-term silencing of HIV-1 transcriptionMakoto Yamagishi, Takaomi Ishida, Ariko Miyake, et al.
Pageof 33

Showing results (71-80 of 324) with videos related to

Sort By:
Pageof 33
AIDS (London, England)|July 30, 2005
Evaluation of ultrasound for assessing facial lipoatrophy in a randomized, placebo-controlled trialDianne Carey, Handan Wand, Allison Martin, et al.
Journal of Chemical Information and Modeling|January 17, 2025
Intracellular Pocket Conformations Determine Signaling Efficacy through the μ Opioid ReceptorDavid A Cooper, Joseph DePaolo-Boisvert, Stanley A Nicholson, et al.
AIDS Research and Human Retroviruses|June 3, 2005
A new variant cytotoxic T lymphocyte escape mutation in HLA-B27-positive individuals infected with HIV type 1Palanee Ammaranond, John Zaunders, Claudette Satchell, et al.
Plos One|November 3, 2011
Predictors of limb fat gain in HIV positive patients following a change to tenofovir-emtricitabine or abacavir-lamivudineAllison Martin, Janaki Amin, Sean Emery, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2024
Intracellular pocket conformations determine signaling efficacy through the <math></math> opioid receptorDavid A Cooper, Joseph DePaolo-Boisvert, Stanley A Nicholson, et al.
Sexual Health|January 9, 2017
Managing two decades of visceral leishmaniasis and HIV co-infection: a case report that illustrates the urgent research needs in the fieldMelissa L Kelly, Angie N Pinto, Dan Suan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 27, 2012
Tuberculosis after commencing antiretroviral therapy for HIV infection is associated with elevated CXCL9 and CXCL10 responses to Mycobacterium tuberculosis antigensBenjamin G Oliver, Julian H Elliott, Patricia Price, et al.
AIDS (London, England)|December 4, 2002
Thymidine analogue withdrawal for lipoatrophic patients on protease-sparing therapy improves lipoatrophy but compromises antiviral control: the PIILR extension studyDon E Smith, Andrew Carr, Matthew Law, et al.
Journal of Clinical Epidemiology|April 29, 2018
National characteristics and trends in antiretroviral treatment in Australia can be accurately estimated using a large clinical cohortRobin Huang, Kathy Petoumenos, Richard T Gray, et al.
Microbes and Infection|February 24, 2009
Retroviral delivery of promoter-targeted shRNA induces long-term silencing of HIV-1 transcriptionMakoto Yamagishi, Takaomi Ishida, Ariko Miyake, et al.
Pageof 33